CRP and synovitis: In order to determine whether miRNA expression can be used as a biomarker to predict disease development, blood samples were also taken from a cohort of 10 “at-risk individuals” who present with joint pain (arthralgia), but do not show clinical signs of synovitis or raised CRP.